PAUL A FRIEDMAN Insider Trading $SNTA MADRIGAL PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL A FRIEDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).

PAUL A FRIEDMAN in MADRIGAL PHARMACEUTICALS, INC.

Trading Symbol: SNTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Chief Executive Officer, Director
Holdings: 161,128 shares
Latest Transaction: Feb 23 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL A FRIEDMAN in MADRIGAL PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2021SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA119.4950,0005,974,50050,000
Mar 05 2020SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA91.7950,0004,589,50050,000
Mar 11 2019SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA127.9650,0006,398,00050,000
Nov 23 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP117.884,000471,520161,128157.1 K to 161.1 K (+2.55 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP124.004,000496,000157,128153.1 K to 157.1 K (+2.61 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
Mar 05 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA124.4550,0006,222,50050,000
Mar 06 2017SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA15.8049,600783,68049,600
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA9.45287,1152,713,237287,115
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00729,0660729,0660 to 729.1 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00143,5570143,703146 to 143.7 K (+98,326.71 %)
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.0014601460 to 146
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.001,13606,8175.7 K to 6.8 K (+20.00 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.005,68105,6810 to 5.7 K

Page:   1